Document Detail

Antiarrhythmic drug therapy in the treatment of atrial fibrillation.
MedLine Citation:
PMID:  8950053     Owner:  NLM     Status:  MEDLINE    
Treatment of atrial fibrillation is often unsatisfactory because no available drug has been shown to be clearly superior for maintaining patients in sinus rhythm, and all agents have significant potential for toxicity. Selection of an antiarrhythmic drug is more likely to be based on the drug's potential for toxicity, rather than its demonstrated superior efficacy in the treatment of atrial fibrillation. Careful assessment of each patient for contraindications to individual agents and the likelihood of treatment success needs to be done before initiating antiarrhythmic therapy.
F Jung; J P DiMarco
Related Documents :
8070493 - Drug therapy of supraventricular tachyarrhythmias--based on efficacy or futility?
943223 - Control of recurrent supraventricular tachycardia with amiodarone hydrochloride.
24071483 - Use of drugs related to the treatment of diabetes mellitus and other cardiovascular ris...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology clinics     Volume:  14     ISSN:  0733-8651     ISO Abbreviation:  Cardiol Clin     Publication Date:  1996 Nov 
Date Detail:
Created Date:  1997-03-14     Completed Date:  1997-03-14     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8300331     Medline TA:  Cardiol Clin     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  507-20     Citation Subset:  IM    
Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amiodarone / therapeutic use
Anti-Arrhythmia Agents / pharmacology,  therapeutic use*
Atrial Fibrillation / drug therapy*,  etiology,  physiopathology
Clinical Trials as Topic
Flecainide / therapeutic use
Ion Channels / drug effects
Quinidine / therapeutic use
Sotalol / therapeutic use
Sulfonamides / therapeutic use
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Ion Channels; 0/Sulfonamides; 130350-52-6/ibutilide; 1951-25-3/Amiodarone; 3930-20-9/Sotalol; 54143-55-4/Flecainide; 56-54-2/Quinidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lessons from animal models of atrial arrhythmias.
Next Document:  Pharmacologic control of heart rate in atrial fibrillation.